China’s young biosimilars sector
27 December 2019
Life Sciences China’s young biosimilars sector 27 December 2019 Sophie Cairns China's young biosimilars sector saw a major milestone in December...
Customer Logins
Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Customer Logins
Sophie Cairns
Senior Research Analyst, Life Sciences, IHS Markit
Sophie Cairns is a senior research analyst in the IHS Markit Life Sciences practice, covering the Asia-Pacific region.
Ms. Cairns focuses on the Asia-Pacific region for the Life Sciences team at IHS Markit. Prior to joining IHS Markit she worked in several consulting and analytical roles, focusing in particular on pricing and reimbursement issues in China. Previously, she had worked as a journalist for seven years, mostly as a foreign correspondent for Reuters newswire in Hong Kong, Shanghai and Paris. Sophie Cairns holds a Master of Science degree in public health from the London School of Hygiene and Tropical Medicine, United Kingdom. She is fluent in Chinese (Mandarin and Cantonese), French and German.
Related Content
-
-
South Korean pharma dreams struggle
01 October 2019Life Sciences South Korean pharma dreams struggle 01 October 2019 Sophie Cairns In September, South Korean drugmaker Hanmi Pharmaceutical signed...
-
Inconsistent application of pricing policies in China contributes to pockets of high prices
17 June 2019Life Sciences Inconsistent application of pricing policies in China contributes to pockets of high prices 17 June 2019 Sophie Cairns China's...
-
HTA adoption in Asian emerging pharma markets
27 September 2018Life Sciences HTA adoption in Asian emerging pharma markets 27 September 2018 Sophie Cairns Asia's emerging markets - such as Indonesia, Vietnam...
-
Regulatory convergence or divergence for Asian pharma
20 September 2018Life Sciences Regulatory convergence or divergence for Asian pharma 20 September 2018 Sophie Cairns Asia is seeing increasing convergence between...
-
Culture shift at Takeda a sign of things to come
10 July 2018Life Sciences Culture shift at Takeda a sign of things to come 10 July 2018 Sophie Cairns Takeda's pursuit of UK pharma major Shire has not...
-
US tariffs likely to mostly affect US generics makers
19 April 2018Life Sciences US tariffs likely to mostly affect US generics makers 19 April 2018 Sophie Cairns On 3 April, the Trump administration threatened...
-
China's new clinical trial regulations a win-win for all
23 October 2017Life Sciences China's new clinical trial regulations a win-win for all 23 October 2017 Sophie Cairns Earlier this month, China took an axe to...
-
In China drugmakers walk increasingly fine line between lower prices and making a buck
04 August 2017Life Sciences In China drugmakers walk increasingly fine line between lower prices and making a buck 04 August 2017 Sophie Cairns In mid-July...
-
Outcry over patient death puts Hong Kong's drug reimbursement system into spotlight
08 June 2017Life Sciences Outcry over patient death puts Hong Kong's drug reimbursement system into spotlight 08 June 2017 Sophie Cairns Hong Kong's drug...
